Drreddys Laboratories | RDY - PE Price to Earnings


Drreddys Laboratories reported 28.78 in PE Price to Earnings for its fiscal quarter ending in September of 2026.





Pe Change Date
ANI Pharmaceuticals 15.46 8.81 Sep/2026
Aurora Cannabis 23.27 0 Mar/2026
Bayer 4.61 0.47 Sep/2026
Cipla 38.39 2.57 Sep/2026
Corcept Therapeutics 86.2 102.04 Sep/2026
Drreddys Laboratories 28.78 9.53 Sep/2026
GlaxoSmithKline 9.72 0.9 Sep/2026
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Lonza 34.34 2.58 Dec/2025
Novartis 19.17 3.24 Sep/2026
Pacira 80.9 45.22 Sep/2026
Phibro Animal Health 13.82 4.04 Dec/2025
Prestige Brands 11.89 3.75 Jun/2026
Richter Gedeon 11.5 0.72 Jun/2026
Sun Pharmaceuticals 37.28 1.1 Sep/2026
Supernus Pharmaceuticals 72.26 6.89 Sep/2026
Teva Pharmaceutical Industries 18.7 5.9 Sep/2026